(A) PRUNE2 and PCA3 expression in tumor (n=107) (Figure 1—source data 1) and nonneoplastic (n=24 for PRUNE2, n=21 for PCA3) (Figure 1—source data 1) prostatic samples. This evidence concerns the gene PCA3 and neoplasm.